You are here:

Seretide 50 Evohaler (Salmeterol xinafoate 25mcg/fluticasone propionate 50mcg)

Advice

Following an abbreviated submission.

Seretide 50 Evohaler??is accepted for use within NHS Scotland for the regular treatment of asthma where use of a combination of the long-acting beta agonist salmeterol and the inhaled corticosteroid fluticasone is appropriate for a child aged 4-12 years.

The acquisition cost of the combination product is less than for the individual components given by aerosol inhalation and for the combination given by Accuhaler?.

Drug Details

Drug Name: Seretide 50 Evohaler (Salmeterol xinafoate 25mcg/fluticasone propionate 50mcg)
SMC Drug ID: 108/04
Manufacturer: GlaxoSmithKline UK Ltd
Indication: Asthma
BNF Category:
Sub Category: 3.2 Corticosteroids
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 12 July 2004

Back